SCHEMBL8438113

SCHEMBL8438113

COC(=O)OC1=C(C)N(C)C(C)=C(C(C)=O)C1c1ccc(Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.60
NPSR1 Q6W5P4 4/20 0.60
KDM4E B2RXH2 3/20 0.60
SMN1; SMN2 Q16637 1/20 0.51
TSHR P16473 5/20 0.45
HSD17B10 Q99714 3/20 0.45
GPBAR1 Q8TDU6 1/20 0.44
LMNA P02545 4/20 0.44
HTT P42858 3/20 0.41
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 3/20 0.39
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
ALOX12 P18054 1/20 0.37
CACNA1F O60840 1/20 0.37
CACNA1D Q01668 1/20 0.37
CACNA1S Q13698 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8442358 0.88 TSHR (0.45) HPGDNPSR1KDM4ESMN1; SMN2TSHR
SCHEMBL8441182 0.87 NPSR1 (0.44) HPGDNPSR1KDM4ETSHRHSD17B10
SCHEMBL8437356 0.83 ADORA3 (0.42) HPGDNPSR1KDM4ETSHRHSD17B10
SCHEMBL8437325 0.82 KDM4E (0.69) HPGDNPSR1KDM4ESMN1; SMN2TSHR
SCHEMBL8345995 0.82 NPSR1 (0.89) HPGDNPSR1KDM4ESMN1; SMN2TSHR
SCHEMBL8441847 0.81 NPSR1 (0.40) HPGDNPSR1KDM4ESMN1; SMN2TSHR
SCHEMBL8438121 0.79 TSHR (0.41) HPGDNPSR1KDM4ETSHRHSD17B10
SCHEMBL8441926 0.79 TSHR (0.42) HPGDNPSR1KDM4ESMN1; SMN2TSHR
SCHEMBL8437311 0.79 CACNA1F (0.51) HPGDNPSR1KDM4ESMN1; SMN2TSHR
SCHEMBL8321061 0.78 HPGD (0.41) HPGDNPSR1KDM4ESMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0717036-B1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS BAYER AG (DE) 1999-03-17 EP claimed
EP-0717036-A1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS BAYER AG (DE) 1996-06-19 EP claimed
EP-0717036-B1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS BAYER AG (DE) 1999-03-17 EP disclosed
EP-0717036-A1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS BAYER AG (DE) 1996-06-19 EP disclosed